中文         Site Map |
 
 
 
Fosun Pharma Set Up A Subsidiary Company in Côte d'Ivoire
Date: Jul.19.2012
 

On July 19th, 2012, Fosun Pharma participated in the closing ceremony of the Fourth Conference of Chinese and African Entrepreneurs in Beijing, and signed an agreement on the investment of Fosun-Guilin Pharma Afrique Francophone Sarl. Fosun Pharma will establish a joint venture pharmaceutical company, Fosun-Guilin Pharma Afrique Francophone Sarl (GPAF), in Abidjan of Cote D’ivoire, to cover the territories of West Africa. Mr Li Ligong, one of the top management of Fosun Group, Mr Yu Zhemin, the chairman of Guilin Pharma and Mr. Jean-Marc Bouchez, general manager of GPAF attended the ceremony and signed the contract there.

It is reported that the investment of GPAF is the only representative project on pharmaceutical industry among eight projects presented during the China-Africa Forum. As a high-tech pharmaceutical company strategizing on the research and development on artesunate, it innovates and develops artesunate based antimalarial, which has also driven its business on generic pharmaceutical products in West Africa region. Meanwhile Guilin Pharma develops anti-infective product line, its business has reached to 17 French-speaking countries, as Côte d'Ivoire, Senegal, Cameroon, Gabon, Niger, Chad, Democratic Republic of the Congo (DRC), Congo (Brazzaville), Mauritania, Burkina Faso, Benin, Togo, Burundi, Madagascar, Mali, Guinea, Central Africa, which contributes as a solid foundation for Fosun Pharma’s business development in West African countries.

Fosun Pharma focuses on modern biopharmaceutical industry and health industry covering several important business sectors in the pharmaceutical industry chain including R&D, manufacturing, distribution and retail. With the rapid development of Chinese pharmaceutical market and the Chinese pharmaceutical company’s overseas business, Fosun Pharma has become a large professional pharmaceutical group with R&D and manufacturing as its core, enjoying leading market shares in medicine distribution, medical care, medical diagnostic and medical devices, and has key advantages in R&D, marketing, integration and human resource.

Guilin Pharmaceutical Co., Ltd, a member of Fosun Pharma group, is the first pharmaceutical manufacturer whose oral and parenteral antimalarials pre-qualified by WHO in the world. Its Artesun (artesunate for injection), WHO pre-qualified in November, 2010, is recommended by WHO Guidelines for the Treatment of Malaria as the preferred choice on treating severe malaria in adult and children, and is the only injectable artesunate complying with international quality standard so far. To expand the international market, Guilin Pharma has set up four branch offices in Myanmar (Asia), Nigeria, Kenya and Uganda (Africa) and one subsidiary company in Ghana, to cover almost all malaria endemic English-speaking countries.

 

This site is published by Guilin Pharmaceutical (Shanghai) Corporation,        which is solely responsible for its content. All rights reserved.

© Guilin Pharmaceutical (Shanghai) Co., Ltd. 2017.